Yasmeen Rahimi

Yasmeen Rahimi, PhD, is an accomplished professional in the biotechnology sector, currently serving as Managing Director and Senior Research Analyst at Piper Sandler since July 2020. Concurrently, Yasmeen holds the position of Director and Biotechnology Research Analyst at ROTH Capital Partners, a role started in September 2017. Previous experience includes significant roles at H.C. Wainwright & Co., LLC and Guggenheim Partners, where Yasmeen contributed to biotechnology equity research. Academic credentials include a Postdoctoral Fellowship at Yale University School of Medicine and a Ph.D. in Biochemistry from Indiana University School of Medicine, alongside a Master of Science from Purdue University and a Bachelor of Science from Butler University.